• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Lexeo, Abivax File for IPOs on Nasdaq Amid Industry-Wide Drought

cafead

Administrator
Staff member
  • cafead   Oct 02, 2023 at 10:42: AM
via Genetic medicines biotech Lexeo Therapeutics and immune-focused French company Abivax both filed for their initial public offerings on Friday. Neither company specified how much they were seeking to raise in their respective SEC filings.

article source